Nachrichten zur Hims & Hers Health Inc. Aktie

Up 298% in a Year, Is Hims & Hers Health Still a Buy? @themotleyfool #stocks $HIMS

The healthcare company is on fire, and its still cheap by many measures.…

Up 298% in a Year, Is Hims & Hers Health Still a Buy?

The healthcare company is on fire, and its still cheap by many measures.…

Up 298% in a Year, Is Hims & Hers Health Still a Buy?

The healthcare company is on fire, and its still cheap by many measures.…

Up 298% in a Year, Is Hims & Hers Health Still a Buy?

Shares of Hims & Hers Health (NYSE: HIMS) have been on fire over the past year, but theyre not expensive…

3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance

Hims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to…

WealthPlan Investment Management LLC Makes New $1.04 Million Investment in Hims & Hers Health, Inc. (NYSE:HIMS)

WealthPlan Investment Management LLC acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free…

Hims & Hers Health (HIMS) Turning Heads with Record Revenue Growth

Hims Hers Health ($HIMS) is turning heads, making substantial strides, and grabbing investors’ attention. Its strategy centered on the…

Hims & Hers Healths (NYSE:HIMS) Strong Earnings Are Of Good Quality

Hims & Hers Health, Inc. ( NYSE:HIMS ) just reported some strong earnings, and the market reacted accordingly with a...…

Hims & Hers Health, up 20%, hits all-time high (HIMS:NYSE)

Hims & Hers Health stock soars 20% as TD Cowen raises price target…

Wachstumsaktie im Höhenflug: Hims profitiert von politischem Rückenwind!

Meine favorisierte Wachstumsaktie legt heute weitere 20 % zu, wodurch Leser des GROWTH-Magazins ihren Einsatz nun vervierfacht haben. Der aktuelle…

Hims & Hers Shares Jump 17%: Explosive Growth, Insider Confidence, and Big Money Moves

Wall Street piles in as insiders hold strong and institutional investors boost stakes in this telehealth powerhouse.…

Hims & Hers Health (NYSE:HIMS) Sets New 52-Week High Following Analyst Upgrade

Hims & Hers Health (NYSE:HIMS) Hits New 1-Year High on Analyst Upgrade…

Hims & Hers Health Inc (HIMS) Shares Up 23.24% on Nov 11

Shares of Hims & Hers Health Inc (HIMS) surged 23.24% in mid-day trading on Nov 11. The stock reached an…

Robeco Institutional Asset Management B.V. Buys New Shares in Hims & Hers Health, Inc. (NYSE:HIMS)

Robeco Institutional Asset Management B.V. bought a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…

Hims & Hers: Undeservedly Undervalued

…

Hims & Hers: A High-Growth Gem On The Verge Of Big Upside

…

Hims & Hers: A High-Growth Gem On The Verge Of Big Upside (NYSE:HIMS)

Hims & Hers is revolutionizing telehealth and wellness for millennials and Gen Z with rapid revenue growth and positive net…

Hims & Hers Health (NYSE:HIMS) Stock Price Expected to Rise, TD Cowen Analyst Says

TD Cowen upped their price target on Hims & Hers Health from $25.00 to $28.00 and gave the company a…

Earnings Estimates Moving Higher for Hims & Hers Health (HIMS): Time to Buy?

Hims & Hers Health, Inc. (HIMS) could be a solid choice for investors given the companys remarkably improving earnings outlook.…

Hims & Hers - Telemedizinspezialist profitiert massiv von dynamischem Neukundenwachstum bei Adipositas-Nachahmerpräparaten!

Geschäftstreiber: Hims &Hers (HIMS) gehört zu den führenden US-Anbietern im Bereich Telemedizin, wobei man Patienten bei sensiblen gesundheitlichen Themenbereichen wie…

Hims & Hers price target raised to $28 from $25 at TD Cowen

TD Cowen analyst Jonna Kim raised the firm’s price target on Hims Hers to $28 from $25 and keeps…

After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?

Hims & Hers strong performance involves much more than just GLP-1 drugs.…

After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy? @themotleyfool #stocks $HIMS

Hims & Hers strong performance involves much more than just GLP-1 drugs.…

Hims & Hers health chief medical officer Carroll sells $331,093 in stock By Investing.com

Hims & Hers health chief medical officer Carroll sells $331,093 in stock…

Hims & Hers CEO Andrew Dudum sells $6.9 million in stock By Investing.com

Hims & Hers CEO Andrew Dudum sells $6.9 million in stock…

Hims & Hers chief commercial officer sells $45,188 in stock By Investing.com

Hims & Hers chief commercial officer sells $45,188 in stock…

Hims & Hers Health Inc (HIMS) Stock Price Up 2.82% on Nov 7

Shares of Hims & Hers Health Inc (HIMS) surged 2.82% in mid-day trading on Nov 7. The stock reached an…

Seaport Res Ptn Has Positive Outlook of HIMS FY2024 Earnings

Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Research analysts at Seaport Res Ptn upped their FY2024…

Stock Traders Purchase High Volume of Hims & Hers Health Call Options (NYSE:HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) saw unusually large options trading activity on Wednesday. Stock investors…

Hims & Hers: Why This Healthcare Stocks Growth Makes It a Buy

Most investors would look at an earnings announcement as a past event, connecting the current price action in the stock…

Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy

According to analysts, even after a 6% rally on the morning of the earnings announcement, Hims & Hers stock might…

Hims & Hers Health Third Quarter 2024 Earnings: Beats Expectations

Hims & Hers Health ( NYSE:HIMS ) Third Quarter 2024 Results Key Financial Results Revenue: US$401.6m (up 77% from 3Q...…

Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Hims & Hers Health, Inc. ( NYSE:HIMS ) investors will be delighted, with the company turning in some strong numbers...…

Leerink Partnrs Has Bullish Estimate for HIMS Q4 Earnings

Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Analysts at Leerink Partnrs upped their Q4 2024 earnings…

Q4 EPS Estimate for Hims & Hers Health Boosted by Analyst

Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Research analysts at Seaport Res Ptn upped their Q4…

Hims & Hers stock rallies amidst increased revenue, GLP-1 generic

The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of…

Hims & Hers Health (NYSE:HIMS) Announces Quarterly Earnings Results, Beats Expectations By $0.26 EPS

Hims & Hers Health (NYSE:HIMS - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.32…

Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24 By Investing.com

Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24…

Whats Going On With Hims & Hers Health Stock Tuesday? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and…

Hims & Hers Health: Another Blowout Quarter Ignored (NYSE:HIMS)

Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the market. Learn more HIMS…

Hims & Hers will start selling a generic weight loss drug

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of…

Hims & Hers will start selling a generic weight loss drug

The telehealth company will start offering a generic version of liraglutide in 2025 as consumers continue to struggle to secure…

Hims & Hers Health (NYSE:HIMS) Shares Gap Up After Better-Than-Expected Earnings

Hims & Hers Health (NYSE:HIMS) Shares Gap Up on Strong Earnings…

Revenue Soars 77% for Hims & Hers Health, Inc. in Q3 2024

In the third quarter, the brands eclipsed two million subscribers on its platform, with more than 1 million utilizing a…

Hims & Hers Reports High Success Rate in GLP-1 Program

Hims & Hers has released a white paper showing that 87% of its GLP-1 weight loss program customers are close…

Hims & Hers Stock Soars: First Generic Weight Loss Drug to Shake Up Billion-Dollar Market

Shares jump over 5% as Hims & Hers unveils plans for the first generic GLP-1--targeting Novos weight-loss dominance…

Hims & Hers Stock Soars: First Generic Weight Loss Drug to Shake Up Billion-Dollar Market

Shares jump over 5% as Hims & Hers unveils plans for the first generic GLP-1--targeting Novos weight-loss dominance…

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

Hims & Hers both revenue channels witness strong revenue growth on the back of solid product demand in the third…

Hims & Hers Soars Pre-Market After Analysts Boost Price Targets On Strong Q3 Performance

Hims & Hers Health raised its full-year sales guidance to $1.46 billion to $1.465 billion, up from a forecast in…

Hims & Hers price target raised to $32 from $28 at Seaport Research

Seaport Research raised the firm’s price target on Hims Hers to $32 from $28 and keeps a Buy rating…